PROFILE |
 |
UCB is a chemical and pharmaceutical group active in three industrial sectors: pharmaceuticals, chemicals, and films. The Pharma division, accounting for more than 50% of sales, makes prescription drugs and other medicines, including Lortab (pain reliever), Nootropil (cerebral function regulator), and Zyrtec (antiallergic). UCB Chemicals produces adhesives, coatings for industrial and home use, and methylamines. The company's Film division makes celluloid and plastic packaging films for the cosmetics and food industries. UCB operates in more than 100 countries worldwide.
COMPETITION |
 |
Johnson & Johnson (JNJ)
Merck & Co., Inc. (MRK)
Novartis AG (NVS)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 1,854.90
1-Yr. Sales Growth: (3.4)%
Employees: 9,214
Revenue per employee: $201,313.22
KEY PEOPLE |
 |
Georges Jacobs
CEO
Vincent Damien
CFO
CONTACT INFO |
 |
Allée de la Recherche 60
B-1070 Brussels, Belgium
Phone: 32-2-559-99-99
Fax: 32-2-559-95-71
Online: Web Site
|